tiprankstipranks
Honeywell still exploring alternatives, Capri weighs Versace sale: Morning Buzz
PremiumThe FlyHoneywell still exploring alternatives, Capri weighs Versace sale: Morning Buzz
2M ago
Morning Movers: Viridian and Edgewise jump following successful trials
Premium
The Fly
Morning Movers: Viridian and Edgewise jump following successful trials
2M ago
Viridian Therapeutics Achieves Milestone in Phase 3 Trial
Premium
Company Announcements
Viridian Therapeutics Achieves Milestone in Phase 3 Trial
2M ago
Viridian Therapeutics Advances in Biotech Innovations
PremiumCompany AnnouncementsViridian Therapeutics Advances in Biotech Innovations
3M ago
Viridian Therapeutics reports Q3 EPS ($1.15), consensus ($1.06)
Premium
The Fly
Viridian Therapeutics reports Q3 EPS ($1.15), consensus ($1.06)
3M ago
Is VRDN a Buy, Before Earnings?
Premium
Pre-Earnings
Is VRDN a Buy, Before Earnings?
3M ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
4M ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
5M ago
Viridian Therapeutics price target raised to $44 from $35 at RBC Capital
Premium
The Fly
Viridian Therapeutics price target raised to $44 from $35 at RBC Capital
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100